Transaction · 0001225208-25-002921

Jones Nicole S

Jones Nicole S, SR, reported an open-market or private sale at Cigna Group involving 4904.000000 shares for an estimated $1511020.48. Reported holdings after the transaction were 29421.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SSR
CICigna Group
Filing timeMar 05
Trade dateMar 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CI price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CI since 2025-03-05Filed 548 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001225208-25-002921
Common Stock, $.01 Par Value
Transaction date
Mar 03, 2025
Filed Mar 05, 2025, 12:52 AM · 2d delay
Shares
4.90k sh
$30.8k per share
Estimated value
-$151M
Computed from shares × price
Holdings after
29.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common…

  2. F2

    These restricted shares vest in three equal annual installments beginning March 1, 2026.

  3. F3

    Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

  4. F4

    Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

  5. F5

    This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.

  6. F6

    Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

  7. F7

    This option vests in three equal annual installments beginning March 1, 2026.

Original filing · 0001225208-25-002921
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CI